Navigation Links
Artificial Ankle Takes Giant Step Forward
Date:6/18/2009

Newly approved device allows pain-free mobility, experts say

THURSDAY, June 18 (HealthDay News) -- The world has taken another step -- a flexible and strong step -- toward achieving the bionic (wo)man.

The U.S. Food and Drug Administration recently approved what appears to be the first artificial ankle that allows range of motion in the joint.

Known as the Scandinavian Total Ankle Replacement , or STAR, system, it was approved in May after four years of study involving 224 people.

"The STAR prosthesis is the only one with a mobile bearing," said Dr. Roger Mann, an orthopedic surgeon in Oakland, Calif., co-editor of the classic textbook Surgery of the Foot & Ankle and one of the principal investigators of the clinical trial that led to the device's approval. "That's one of the factors that gives movement."

"It allows people to walk without pain," he continued. "These people are really miserable before. They just can't get around. Every time they try to walk, they have pain, and, as a result, it limits their activities."

But now, Mann said, "they can walk and hike and play golf, play doubles tennis (as long as they don't get into it too much), ski and do all activities of daily living. You're not being restricted very much."

Dr. Judith Baumhauer, associate chairwoman of academic affairs in the orthopedics department at the University of Rochester Medical Center, described the new ankle as revolutionary. "There have been ankle replacements on the market, but they took them off because they were poorly designed," she said. "This is different because it has three components."

The STAR ankle, designed in 1978 by a Danish doctor, has helped Europeans walk for about 10 years.

Mann learned of the prosthesis when giving a speech on ankle replacements -- specifically, ankle fusions -- at a conference in Denmark.

"Ankle fusions work pretty well, but
'/>"/>

Copyright©2009 ScoutNews,LLC.
All rights reserved  

Page: 1 2 3

Related medicine news :

1. Dr. Dean Dornic Certified to Perform Artificial Cornea Transplant
2. Automated Artificial Pancreas Controls Blood Glucose Levels in Diabetes Patients for First Time
3. Artificial liver may extend lives
4. New Video Series Spotlights Role of Biomedical Engineers in Caring for Total Artificial Heart Patients
5. INTERMACS: Total Artificial Heart Bridge-to-Transplant Rate 2x Higher at 6 Months Than BiVADS and LVADs
6. Total Artificial Heart Patient 3rd in the World to Receive Dual Transplants
7. SynCardia Introduces New 12-lb Freedom Discharge Driver Designed to Provide Quality 'Lifestyle' for Total Artificial Heart Patients
8. Artificial pump effectively backs up failing hearts
9. Researchers Successfully Create Computer-Simulated Model for Evaluating Artificial Pancreas
10. Artificial disc replacement as good or better than spinal fusion surgery
11. New Technology May Boost Artificial Arms

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Artificial Ankle Takes Giant Step Forward
Artificial Ankle Takes Giant Step Forward
(Date:12/1/2009)..., , RED BANK, N.J., Dec. 1 /PRNewswire/ ...rs know breastfeeding is ideal for their babies an...o decide what works best for them and their famili...inr.mediaseed.tv/IFC_37156/ ,, The survey of m...d that most mothers (83%) made their infant feedin...
(Date:12/1/2009)...iscovery could aid in development of simple screen...1 (HealthDay News) -- In a finding that could lead... U.S. researchers have identified immune system ma...ple at high risk for lung cancer. , The researc...mples from 137 people with non-small cell lung ca...
(Date:12/1/2009)...DC urges H1N1 vaccination because pandemic,s cours.... 1 (HealthDay News) -- A U.S. health official sai... be on the wane nationally, but many experts agree...r. , The flu is now widespread in 32 states -- ... Frieden, director of the U.S. Centers for Disease...
(Date:12/1/2009)... Ever thought you could qu...! Kevin Arthur Smith,s groundbreaking new system f...y, permanent. In just twenty eight days your cravi... , (PRWEB) December 1, 20...uring her eight-year addiction to nicotine, smokin...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /P...and a global leader in the development and deliver...for the medical, scientific and academic markets, ...versal Search, our first-to-market cross-platform ...sychology lexicon, based on the American Psycholog...
Breaking Medicine News(10 mins):Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3
...ill, arsenic also can prolong the lives of patient...aturday found. "This study shows that even...arlier in the course of treatment," said Dr. Bayar...erican Society of Oncology (ASCO) which brought to...
...JAMA, has identified novel genetic mutations linke... that these mutations are due to both independent ...as been released early to coincide with its presen...is the second most common cause of cancer death wo...
...sburgh Medical Center (UPMC) study presented at th...al Oncology (ASCO) in Chicago and published as Abs...ted for follicular lymphoma, a slow-growing type o...to the treatment and since only a short-course of ...
...nounced follow-up data from a Phase 2 clinical tri...ch was conducted by the Johns Hopkins Sidney Kimme...ith operable pancreatic cancer who received GVAX a... to be 26.8 months, a result which compares favora...
...end, even if it is all subtle, as in Canada appare...e hard to pin down is more dangerous to mental hea...dy of 180 Korean immigrants living in Canada. ...lead author Samuel Noh, professor of psychiatry at...
...g of SNM, the world's largest society for molecula...man researchers stated that early metabolic imagin...ely identifies patients responding to chemotherapy...the treatment of common solid tumors," said Ken He...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2
(Date:12/1/2009)...TER, N.J., Dec. 1 Tibotec Therapeu...s, L.P., announced today that it is launching a ne...g women and people of color living with HIV/AIDS. ...ducational events, media outreach and a new Web si...g learnings from the GRACE study, the largest clin...
(Date:12/1/2009)...D CITY, Calif., Dec. 1 Codexis, In...p and the signing of its second agreement this yea...rld,s largest generic drug manufacturer. The new ...products. Codexis announced an earlier agreement ...ent, Teva will use Codexis biocatalysis technology...
(Date:12/1/2009)...STON, Dec. 1 An expert f...XL ), a leading global biopharmaceutical services ...ve approaches to drug development in Asia at the P...ence, being held December 1-3, 2009 at the Interco... of the conference, which is focused on maximizing...
Breaking Medicine Technology:Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 2Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 3Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 4Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 5Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 6Tibotec Therapeutics Launches GRACE Campaign for Women and People of Color Living With HIV/AIDS 7Codexis Expands Collaboration with Teva 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 2PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 3PAREXEL Expert To Lead Panel on Innovative Drug Development in Asia at Partnerships in Clinical Trials Asia Pacific Conference 4What scientists know about jewel beetle shimmer 9338 1What scientists know about jewel beetle shimmer 9338 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 1R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 2R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 3R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 4R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 5R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 6R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 7R788 in TASKi3 Clinical Trial Does Not Meet Efficacy Endpoints in RA Patients Who Had Previously Failed Biologic Therapies Results Incongruent 4774 8Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 1Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 2Renaissance Grants 243 000 to the Florida Dental Association to Present Oral Health Workshops for the Vulnerable Elderly 52615 3
... (Nasdaq: CVTX ) announced today that eight abstr... anti-arrhythmia data from the MERLIN,TIMI-36 stud...pean Society,of Cardiology (ESC) Congress 2007 tak...007. A clinical trial update session entitled, Th... with Electrophysiologic Properties, on the,Incide...
...s, Inc. (Nasdaq: ADLS ), today announced the comm...stitute of Allergy and Infectious,Diseases (NIAID)...fense,research, under which the NIAID will conduct...te-stage antibiotic, as a treatment for,anthrax an...aboration is,part of the U.S. Government,s effort ...
Other Medicine Technology:CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 2CV Therapeutics Announces Eight Abstracts Accepted for Presentation at the European Society of Cardiology Congress 2007 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 2Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 3Advanced Life Sciences Collaborates with U.S. Government to Study Cethromycin as Treatment for Anthrax and Other High-Priority Biodefense Agents 4
Lacrimal Cannula, Curved - Open End.
PremierEdge™ Implant Knives
Universal I/A handpiece - Titanium (Binkhorst Tip)
Universal I/A handpiece - Titanium (Curved Tip, Size: 16g Outer Cannula)
Medicine Products: